As exemplified by PTPRZ1- and NLGN4X-specific T cells, their T cell receptors (TCR) were able to license transgenic T cells to exhibit cytotoxic activity towards target-expressing tumor cell lines, confirming natural processing within the tumor cells. This evidence concerns the gene NLGN4X and neoplasm.